WallStreetZenWallStreetZen

NASDAQ: OMIC
Singular Genomics Systems Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

OMIC past revenue growth

How has OMIC's revenue growth performed historically?
Company
280.52%
Industry
7.53%
Market
17.55%
OMIC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OMIC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
OMIC's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

OMIC earnings and revenue history

Current Revenue
$2.9M
Current Earnings
-$94.8M
Current Profit Margin
-3,257.3%

OMIC Return on Equity

Current Company
-45.3%
Current Industry
11.1%
Current Market
188%
OMIC's Return on Equity (-45.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when OMIC announces earnings.

OMIC Return on Assets

Current Company
-33.3%
Current Industry
7.2%
OMIC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

OMIC Return on Capital Employed

Current Company
-37.92%
Current Industry
9.7%
OMIC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OMIC vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
OMIC$2.91M-$86.50M-$94.82M+280.52%N/A
FEMY$1.07M-$13.17M-$14.25M+3.64%N/A
RVP$43.60M-$1.24M-$7.24M+5.55%N/A
POCI$19.22M-$1.29M-$1.72M+29.71%N/A
NEPH$14.24M-$1.36M-$1.58M+20.15%N/A
View Top Medical Stocks

OMIC earnings dates

Next earnings date
May 28, 2024

Singular Genomics Systems Earnings & Revenue FAQ

What were OMIC's earnings last quarter?

On Invalid Date, Singular Genomics Systems (NASDAQ: OMIC) reported Q4 2023 earnings per share (EPS) of -$0.31, up 3.33% year over year. Total Singular Genomics Systems earnings for the quarter were -$23.25 million. In the same quarter last year, Singular Genomics Systems's earnings per share (EPS) was -$0.30.

If you're new to stock investing, here's how to buy Singular Genomics Systems stock.

What was OMIC's earnings growth in the past year?

As of Q2 2024, Singular Genomics Systems's earnings has grown year over year. Singular Genomics Systems's earnings in the past year totalled -$94.82 million.

What is OMIC's earnings date?

Singular Genomics Systems's earnings date is Invalid Date. Add OMIC to your watchlist to be reminded of OMIC's next earnings announcement.

What was OMIC's revenue last quarter?

On Invalid Date, Singular Genomics Systems (NASDAQ: OMIC) reported Q4 2023 revenue of $1.08 million up 41.31% year over year. In the same quarter last year, Singular Genomics Systems's revenue was $765.00 thousand.

What was OMIC's revenue growth in the past year?

As of Q2 2024, Singular Genomics Systems's revenue has grown 280.52% year over year. This is 273 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 7.53%. Singular Genomics Systems's revenue in the past year totalled $2.91 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.